22
Thu, Jun
17 New Articles

Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus’ on-demand topical cream for erectile dysfunction

Industry Reports
Typography

Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus’ Vitaros.

Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile dysfunction.Ferring is Apricus’ existing commercialisation partner for Vitaros in Latin America and parts of Europe and Asia. Following an agreed handover period, Ferring will be responsible for managing all Vitaros-related activities outside of the U.S. with existing Vitaros commercialisation partners. Apricus will retain its Vitaros rights in the U.S.

"Urology is a key therapeutic area for Ferring," said Michel Pettigrew, President of the Executive Board and COO, Ferring Pharmaceuticals. “This agreement strengthens our existing portfolio and reinforces Ferring’s commitment to improving the quality of life of patients with a broad range of urological conditions.”

About Ferring Pharmaceuticals
Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. For further information on Ferring or its products, visit www.ferring.com. 

*Vitaros® is a registered trademark of NexMed International Limited, and will be assigned to Ferring B.V. worldwide, excluding the United States.  Such trademark is registered in certain countries throughout the world and pending registration in the United States.

For more information:
Ferring Pharmaceuticals
Lindsey Rodger
Tel. +41 58 451 40 23
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Market Movers

Rogers Corporation Common Stock

NYQ : ROG - 21 Jun, 3:12pm
107.74
+0.83 (+0.78%) After Hours:
Open 107.15 Mktcap 1.95B
High 108.67 52wk Hight 113.26
Low 106.92 52wk Low 51.98
Vol 45017 Avg Vol 125494
Eps 5.33 P/e 32.60
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 21 Jun, 3:13pm
6.54
+0.03 (+0.46%) After Hours:
Open 6.53 Mktcap 95.35B
High 6.57 52wk Hight 6.99
Low 6.51 52wk Low 3.60
Vol 4.52M Avg Vol 8.67M
Eps 0.49 P/e 13.91
Currency: USD

Merck & Company, Inc. Common St

NYQ : MRK - 21 Jun, 3:13pm
65.56
+1.03 (+1.60%) After Hours:
Open 64.56 Mktcap 179.32B
High 65.60 52wk Hight 66.80
Low 64.56 52wk Low 55.10
Vol 7.88M Avg Vol 8.87M
Eps 3.84 P/e 41.78
Currency: USD

Johnson & Johnson Common Stock

NYQ : JNJ - 21 Jun, 3:13pm
135.03
+0.81 (+0.60%) After Hours:
Open 134.29 Mktcap 363.75B
High 135.11 52wk Hight 135.11
Low 134.02 52wk Low 109.32
Vol 3.98M Avg Vol 5.78M
Eps 7.10 P/e 22.70
Currency: USD

Pfizer, Inc. Common Stock

NYQ : PFE - 21 Jun, 3:13pm
34.04
+0.48 (+1.43%) After Hours:
Open 33.61 Mktcap 203.15B
High 34.10 52wk Hight 37.39
Low 33.58 52wk Low 29.83
Vol 19.08M Avg Vol 21.73M
Eps 2.55 P/e 28.65
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 21 Jun, 12:42pm
13.71
-0.03 (-0.24%) After Hours:
Open 13.75 Mktcap
High 13.75 52wk Hight 16.29
Low 13.71 52wk Low 12.60
Vol 1206 Avg Vol 7128
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.
captcha